Researchers have deepened our understanding of two of the five members of the CDKL family of genes, CDKL2 and CDKL1. They show that variants in these genes can lead to neurodevelopmental conditions, including epilepsy, and propose a mechanism by which the defective variants may cause the neurological symptoms in affected individuals.
